Li Zhang

11PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRadiation therapyCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 06, 2026
Inhibition of TGF-β1/Smad signaling reverses the dedifferentiated phenotype of thyroid cancer cells in three-dimensional culture.

|Jun 10, 2026
Loss of CSE couples with BRAF V600E to fuel thyroid cancer metastatic progression through zinc-dependent activation of the EMT machinery.

|May 13, 2025
Lomibuvir sensitizes radioiodine-resistant thyroid cancer cell lines to radioiodine treatment by targeting hTERT RNA-dependent polymerase activity.

Xian Cheng, Shichen Xu, Jing Wu

|Jan 09, 2025
Influence of Body Mass Index on the Clinicopathological Features of Papillary Thyroid Carcinoma in a Chinese Population.

Li Zhang, Shichen Xu, Xian Cheng

|Nov 03, 2023
Risk-stratified Distant Metastatic Thyroid Cancer with Clinicopathological Factors and BRAF/TERT Promoter Mutations.

Xian Cheng, Ying Zhou, Shichen Xu

|Jan 25, 2022
Capsaicin inhibits the stemness of anaplastic thyroid carcinoma cells by triggering autophagy-lysosome mediated OCT4A degradation.

Liying Wu, Shichen Xu, Xian Cheng

Pageof 2

Frequent Collaborators

1 joint publications

Haixia Guan

1 joint publications

Liying Wu

1 joint publications

Rongrong Lu

1 joint publications

Zichao Zhang